dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with cyclic gmp in 1 studies
| Studies (dibutyryl cyclic-3',5'-cytidine monophosphate) | Trials (dibutyryl cyclic-3',5'-cytidine monophosphate) | Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 72 | 0 | 18 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | dibutyryl cyclic-3',5'-cytidine monophosphate (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carretero, OA; Garvin, JL; Ortiz, PA; Ramseyer, VD | 1 |
1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and cyclic gmp
| Article | Year |
|---|---|
Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs.
Topics: Angiotensin II; Animals; Cyclic CMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelin-1; Hypertension; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Donors; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Solute Carrier Family 12, Member 1; Vardenafil Dihydrochloride | 2016 |